TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | -1 | -15 | -1 | -14 | -32 | -13 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/15/04 18:38 | 1/13/04 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Evans John Robert | UT | D | M | 5 | 14.64 | 14 | 0 | 0 | 79 | D | 1 | 27 | 34 | 24 | 8 | 10 | 9 | -1 | 1 | 0 | -15 | -22 | -50 | -52 | |
9/12/03 17:42 | 9/10/03 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Evans John Robert | UT | D | S.m | -774 | 30.98 | 21 | -25 | -25 | 76 | D | -7 | 62 | 104 | 20 | 26 | 21 | 13 | 13 | 0 | -1 | -15 | -1 | -14 | -32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |